The World Health Organisation (WHO) has granted approval for Emergency Use Listing (EUL) to Covaxin, manufactured by Hyderabad-based Bharat Biotech, for global use of the COVID-19 vaccine. Earlier, the WHO’s Technical Advisory Group (TAG) had sought additional clarifications from Bharat Biotech, in order to conduct a final EUL risk-benefit assessment. 

The approval was done on the recommendation of the TAG, an independent advisory panel that provides recommendations to WHO on whether a COVID-19 vaccine can be listed for emergency use under the EUL procedure.